- Report
- June 2022
- 100 Pages
India
From €865EUR$900USD£739GBP
- Report
- July 2020
- 222 Pages
Bangladesh
From €2690EUR$2,800USD£2,300GBP
- Report
- January 2020
- 300 Pages
Middle East
From €3459EUR$3,600USD£2,957GBP
- Report
- June 2021
- 96 Pages
Tunisia, Global
From €5717EUR$5,950USD£4,888GBP
- Report
- August 2022
- 120 Pages
United States
From €4564EUR$4,750USD£3,902GBP
- Report
- February 2024
- 106 Pages
China
From €1730EUR$1,800USD£1,479GBP
- Report
- January 2023
- 73 Pages
India
- Report
- February 2022
- 30 Pages
India
From €432EUR$450USD£370GBP
€865EUR$900USD£739GBP
- Report
- June 2019
- 144 Pages
Vietnam
€1917EUR$1,995USD£1,639GBP
- Report
- March 2024
- 78 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- February 2024
- 102 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- May 2023
- 108 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Report
- February 2024
- 275 Pages
China
From €3843EUR$4,000USD£3,286GBP
- Report
- April 2020
- 120 Pages
Vietnam
€1917EUR$1,995USD£1,639GBP
- Report
- January 2020
- 144 Pages
Vietnam
€1917EUR$1,995USD£1,639GBP
- Report
- July 2019
- 133 Pages
Vietnam
€1917EUR$1,995USD£1,639GBP
- Report
- June 2019
- 92 Pages
Vietnam
The Pharmaceutical Export market is a subset of the global pharmaceutical industry, focusing on the sale of pharmaceutical products to international markets. It involves the export of pharmaceuticals from one country to another, and the import of pharmaceuticals from other countries into the exporting country. The export market is highly competitive, with companies competing for market share and pricing. Companies must also comply with the regulations of the importing country, as well as the exporting country.
The Pharmaceutical Export market is driven by the need for access to new and innovative medicines, as well as the need to reduce costs. Companies must also be aware of the changing regulatory environment, as well as the changing needs of the importing countries.
Some of the major players in the Pharmaceutical Export market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include AstraZeneca, Johnson & Johnson, and Bayer. Show Less Read more